1.Kappa angle on visual quality after regional refractive MIOL implantation in high myopic patients complicated with cataract
Hongdan ZHAO ; Yanan LIU ; Yanfang LI ; Yue DONG
International Eye Science 2026;26(8):1348-1353
AIM: To explore the effect of Kappa angle on changes in visual quality and stereoscopic acuity after regional refractive multifocal intraocular lens(MIOL)implantation in patients with high myopia complicated by cataract.METHODS:A retrospective analysis was conducted on data from patients with normal Kappa angle and high myopia complicated by cataract treated at the hospital from January 2024 to January 2025. Patients were divided into two groups based on the median preoperative Kappa angle(0.182 mm): Group A(0
2.Prospective Study of Disease Occurrence Spectrum in Asymptomatic Residents in Areas with High Incidence of Esophageal Cancer: 16-year Observation of 711 Cases in Natural Population
Qide BAO ; Fangzhou DAI ; Xueke ZHAO ; Jingjing WANG ; Xin SONG ; Zongmin FAN ; Yanfang ZHANG ; Zhuo YANG ; Junfang GUO ; Kan ZHONG ; Qiang ZHANG ; Junqing LIU ; Min LIU ; Lidong WANG
Cancer Research on Prevention and Treatment 2025;52(8):656-660
Objective To understand the disease spectrum of a natural village in an area with high incidence of esophageal cancer to provide a reference for precise prevention and control. Methods From 2008 to 2024, 711 asymptomatic people over the age of 35 years in a natural village with high incidence of esophageal cancer in China were surveyed, and 171 of them were subjected to gastroscopy, biopsy, and pathological examination. All participants were followed up for a long time, and their disease history was recorded. Results A total of 16 years of follow-up were performed, and 703 people were effectively followed up. In 2008, 171 people underwent gastroscopy, and 160 people had biopsy and pathological results in endoscopic screening. By 2024, 76 people had been diagnosed with malignant tumors of 12 different types, and among these people, 45 had esophageal cancer. Conclusion Esophageal cancer remains a significant cause of morbidity and mortality from malignant tumors in this region. Biopsy and pathological examination should be strengthened during gastroscopy, and follow-ups and regular check-ups should be given high importance to reduce the incidence and mortality rates of esophageal cancer.
3.Prospective Study on Tooth Loss and Risk of Esophageal Cancer Among Residents of A Natural Village in Wenfeng District, Anyang City, Henan Province
Jingjing WANG ; Ruihua XU ; Yanfang ZHANG ; Xueke ZHAO ; Qiang ZHANG ; Xin SONG ; Mengxia WEI ; Junfang GUO ; Xuena HAN ; Yaru FU ; Bei LI ; Junqing LIU ; Lingling LEI ; Min LIU ; Qide BAO ; Lidong WANG
Cancer Research on Prevention and Treatment 2025;52(7):548-553
Objective To investigate the relationship between tooth loss and the occurrence of esophageal cancer in a natural village in Wenfeng District, Anyang City, Henan Province. Methods A prospective cohort study was conducted to observe the occurrence of tooth loss and esophageal cancer among the asymptomatic residents of the natural village for 16 years from January 2008 to July 2024. Data were analyzed by chi-square test, binary logistic regression, and restricted cubic spline. Results Among the total population of 711 cases, 136 cases were lost to follow-up and 575 cases were included in the final statistics, including 45 cases with esophageal cancer. Significant statistical difference was found between esophageal cancer patients with and without tooth loss (P<0.05). Logistic regression analysis showed that tooth loss was associated with the occurrence of esophageal cancer (OR=3.977, 95%CI: 1.543-10.255). After the adjustment for confounders, tooth loss
4.Analysis of trends in diagnostic and therapeutic nuclear medicine resources and practices in Henan province
Yanfang ZHAO ; Yuelan XUAN ; Chenzhi JIA ; Qinfu ZHANG
Chinese Journal of Radiological Medicine and Protection 2025;45(3):202-210
Objective:To investigate the basic information of diagnostic and therapeutic nuclear medicine resources and practices in Henan province in 2022, and to assess the equity of their distribution, and to compare them with the 1998 survey result, so as to provide the reference for the allocation of nuclear medicine resources in Henan province.Methods:On-site investigations were conducted on medical institutions in Henan province that carry out diagnostic and therapeutic nuclear medicine practices. By using a combination of Lorenz curve, Gini coefficient and Theil index, the fairness of nuclear medicine resources and practices were assessed based on population distribution in Henan province in 1998 and 2022.Results:In 2022, there were 54 medical institutions in Henan province that carried out diagnostic and therapeutic nuclear medicine practices, with 67 items of nuclear medicine imaging and supporting equipment, and 690 nuclear medicine staff members involved. A total of 200 938 diagnostic clinical nuclear medicine imaging practices were performed throughout the year, with a diagnostic frequency of 2.04 per 1 000 population. Various types of therapeutic nuclear medicine practices were performed on 29 044 individuals, with a frequency of 0.29 per 1 000 population. The Gini coefficients for the distribution of diagnostic nuclear medicine practices, nuclear medicine staff, and practice frequency based on population distribution in Henan province in 1998 were 0.489, 0.505, and 0.526, respectively, and the Theil indices were 0.091 8, 0.172 1, and 0.139 7, respectively. The Gini coefficients for the distribution of nuclear diagnostic medicine equipment, nuclear medicine staff, and practice frequency based on population distribution in Henan province in 2022 were 0.244, 0.246, and 0.363, respectively, and the Theil indices were 0.086 8, 0.145 3, and 0.159 9, respectively.Conclusions:While clinical nuclear medicine in Henan province is rapidly developing, the distribution of various types of nuclear medicine resources and practices is becoming increasingly balanced. However, there still exists a certain degree of imbalance. Additionally, this also demonstrates a correlation between the resource distribution and regional economic development. The rationality of resource allocation needs further optimization.
5.Analysis of ICD-10 coding for leukemia under DRG payment
Yanfang PAN ; Zhen LI ; Hua ZHAO
Modern Hospital 2025;25(4):553-555,559
Leukemia is a common malignant tumor of the blood system,and the accuracy of ICD coding plays a key role in medical record management and DRG grouping.Currently,in clinical practice,both French-American-British(FAB)classifi-cation and World Health Organization(WHO)classification are used for leukemia classification.With the introduction of MICM(morphology,immunology,genetics and molecular biology)technology,the leukemia classification system has become more re-fined,which also increases the complexity of medical record coding.Therefore,medical record coders need to keep up with the forefront of medical development,thoroughly understand the latest classification standards of leukemia,systematically summarize the coding points and ideas for myeloid leukemia,lymphoid leukemia and unclassified leukemia,and clarify the situation where leukemia is coded as the main diagnosis.In the context of DRG payment reform,clinical doctors should accurately fill in the dis-ease diagnosis and surgical operation information on the medical record cover,and when coding the medical record cover,the co-der needs to comprehensively consider the three principles of selecting the main diagnosis and the local DRG grouping rules to en-sure the accurate selection of the main diagnosis,thus improving the accuracy of DRG admission and providing a reliable basis for the rational allocation of medical resources.
6.The biological roles of exosome-encapsulated traditional Chinese medicine monomers in neuronal disorders.
Chen PANG ; Jie ZHANG ; Yujin GU ; Qili ZHANG ; Yanfang ZHAO
Journal of Pharmaceutical Analysis 2025;15(5):101131-101131
A traditional Chinese medicine (TCM) monomer is a bioactive compound extracted from Chinese herbal medicines possessing determined biological activity and pharmacological effects, and has gained much attention for treating neuronal diseases. However, the application of TCM monomers is limited by their low solubility and poor ability to cross the blood-brain barrier (BBB). Exosomes are small extracellular vesicles (EVs) ranging in size from 30 to 150 nm in diameter and can be used as drug delivery carriers that directly target cells or tissues with unique advantages, including low toxicity, low immunogenicity, high stability in blood, and the ability to cross the BBB. This review discusses the biogenesis, components, stability, surface modification, isolation technology, advantages, and disadvantages of exosomes as drug carriers and compares exosomes and other similar drug delivery systems. Furthermore, exosome-encapsulated TCM monomers exert neuroprotective roles, such as anti-inflammation, anti-apoptosis, anti-mitophagy, and anti-oxidation, in various neuronal diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and cerebral ischemia and reperfusion (CI/R) injury, as well as anti-drug resistance, anti-tumorigenesis, anti-angiogenesis, and promotion of apoptosis in brain tumors, providing more inspiration to promote the development of an exosome-based delivery tool in targeted therapy for neuronal diseases.
7.Construction and identification of recombinant fowl adenovirus 4 expressing Cap protein of goose astrovirus virus genotype 2
Xingyu LI ; Yan LI ; Panpan YANG ; Junjie LIU ; Mengjia XIANG ; Yutao ZHU ; Luyao QIU ; Qilong QIAO ; Boshun ZHANG ; Dexin BU ; Chenghao HAN ; Chunmei YU ; Yanfang CONG ; Zeng WANG ; Jianli LI ; Baiyu WANG ; Jun ZHAO
Chinese Journal of Veterinary Science 2025;45(3):443-448,513
To construct a recombinant fowl adenovirus 4(FAdV-4)expressing the Cap protein of goose astrovirus genotype 2(GoAstV-2),the expression cassette of Cap gene was inserted into the natural 1 966 bp deletion region of the FAdV-4 genome in the infectious clone p15A-cm-FAdV4-HNJZ.The resulted recombinant plasmid p15A-cm-FAdV4-HNJZ-Cap/GoAstV-2 was linearized with restriction enzyme and transfected into chicken hepatoma cell line(LMH)to rescue the recombinant FAdV-4 expressing the Cap protein of GoAstV-2,rF Ad V4-Cap/GoAstV-2.After 15 passages in LMH cells,the recombinant rFAdV4-Cap/GoAstV-2 was identified by PCR using primers flanking the insertion site of the Cap gene expression cassette and using viral genome DNA extracted from rFAdV4-Cap/GoAstV-2 infected LMH cells as template.LMH cells were in-fected with 15th passage rFAdV4-Cap/GoAstV-2 and indirect immunofluorescence was performed with a polyclonal antibody against Cap protein as the primary antibody.Western blot was carried out with lysates of rFAdV4-Cap/GoAstV-2 infected LMH cells.The in vitro replication dynamic of the 15th passage of the rFAdV4-Cap/GoAstV-2 was also investigated in LMH cells.The results demonstrated that the Cap gene of GoAstV-2 was presented in the genome of the recombinant vi-rus rF AdV4-Cap/Go Ast V-2,and could be expressed stably.The prepared recombinant virus in this study will lay a foundation for developing inactivated bivalent vaccine candidate against co-in-fection of FAdV-4 and GoAstV-2 in goose.
8.Application of cell block technique in the diagnosis of papillary thyroid carcinoma
Yanpei WANG ; Haiyan CHEN ; Junhong LI ; Yifei LIU ; Wenyu ZHAO ; Liang HE ; Yanfang ZHANG
China Modern Doctor 2025;63(25):41-44,60
Objective To explore the application of cell block(CB)technology in the diagnosis of papillary thyroid carcinoma(PTC).Methods A total of 86 patients with thyroid nodules who were treated at Luoyang Central Hospital Affiliated to Zhengzhou University from February 2023 to December 2024 were retrospectively selected.Before the operation,all patients underwent ultrasound-guided fine needle aspiration biopsy.After the biopsy,the specimens were respectively subjected to cell smear(CS)and CB pathological examinations.Using postoperative pathology as the gold standard,the clinical application value of CS,CB,BRAFV600E gene detection,and combined detection in the preoperative diagnosis of PTC was evaluated.Results A total of 86 patients were included.Among them,42 cases were diagnosed as PTC by postoperative pathology,and 44 cases were benign lesions.The sensitivity(73.81%),specificity(97.73%),positive predictive value(96.88%),negative predictive value(79.63%),and accuracy(86.05%)of CB in the preoperative diagnosis of PTC were significantly higher than those of CS.The Kappa consistency test results showed that the consistency between CB pathological results and postoperative pathological results was better than that of CS.Receiver operating characteristic curve analysis indicated that the area under the curve(AUC)of CB was significantly higher than that of CS(0.858 vs.0.743,Z=2.391,P=0.017).Furthermore,the combination of CB and BRAFV600E gene detection further improved preoperative diagnostic performance,with a consistency with postoperative pathological results(Kappa=0.837)superior to other examination methods,and an AUC(0.918)significantly higher than other examination methods.Conclusion CB has significant clinical application value in the preoperative diagnosis of PTC,with diagnostic performance significantly superior to CS.Further combination with BRAFV600E gene detection can significantly improve preoperative diagnostic accuracy.
9.Analysis of trends in diagnostic and therapeutic nuclear medicine resources and practices in Henan province
Yanfang ZHAO ; Yuelan XUAN ; Chenzhi JIA ; Qinfu ZHANG
Chinese Journal of Radiological Medicine and Protection 2025;45(3):202-210
Objective:To investigate the basic information of diagnostic and therapeutic nuclear medicine resources and practices in Henan province in 2022, and to assess the equity of their distribution, and to compare them with the 1998 survey result, so as to provide the reference for the allocation of nuclear medicine resources in Henan province.Methods:On-site investigations were conducted on medical institutions in Henan province that carry out diagnostic and therapeutic nuclear medicine practices. By using a combination of Lorenz curve, Gini coefficient and Theil index, the fairness of nuclear medicine resources and practices were assessed based on population distribution in Henan province in 1998 and 2022.Results:In 2022, there were 54 medical institutions in Henan province that carried out diagnostic and therapeutic nuclear medicine practices, with 67 items of nuclear medicine imaging and supporting equipment, and 690 nuclear medicine staff members involved. A total of 200 938 diagnostic clinical nuclear medicine imaging practices were performed throughout the year, with a diagnostic frequency of 2.04 per 1 000 population. Various types of therapeutic nuclear medicine practices were performed on 29 044 individuals, with a frequency of 0.29 per 1 000 population. The Gini coefficients for the distribution of diagnostic nuclear medicine practices, nuclear medicine staff, and practice frequency based on population distribution in Henan province in 1998 were 0.489, 0.505, and 0.526, respectively, and the Theil indices were 0.091 8, 0.172 1, and 0.139 7, respectively. The Gini coefficients for the distribution of nuclear diagnostic medicine equipment, nuclear medicine staff, and practice frequency based on population distribution in Henan province in 2022 were 0.244, 0.246, and 0.363, respectively, and the Theil indices were 0.086 8, 0.145 3, and 0.159 9, respectively.Conclusions:While clinical nuclear medicine in Henan province is rapidly developing, the distribution of various types of nuclear medicine resources and practices is becoming increasingly balanced. However, there still exists a certain degree of imbalance. Additionally, this also demonstrates a correlation between the resource distribution and regional economic development. The rationality of resource allocation needs further optimization.
10.The application status, challenges and prospects of artificial intelligence in communicable diseases prevention and control of health facilities in China
Wenjia ZHAO ; Huilai MA ; Wenshang HU ; Yanfang GAO ; Jie LI ; Zihan LI ; Xinyu LIU ; Yu BING ; Yuehua HU ; Chengdong XU
Chinese Journal of Preventive Medicine 2025;59(8):1328-1339
This study examines the progress and application of Artificial Intelligence (AI) in the prevention and control of infectious diseases within Chinese healthcare institutions. It analyzes the difficulties and challenges encountered during implementation to promote the intelligent transformation and upgrading of infectious disease prevention and control. The results indicate that AI technology has made progress in areas such as infectious disease surveillance and early warning, risk assessment and emergency response, screening and detection, image-based diagnosis and analysis, and health management. Nevertheless, significant challenges remain, including limited application depth and breadth, issues with data quality and privacy protection, insufficient technological maturity and interpretability, potential legal risks, and a shortage of interdisciplinary professionals. To advance the application of AI technology in infectious disease prevention and control and support the modernization of China′s relevant systems, recommendations include strengthening policy support, establishing data standards and robust privacy protection mechanisms, increasing R&D investment, refining laws and regulations, and enhancing the training of interdisciplinary talent.

Result Analysis
Print
Save
E-mail